← All companies

IPSC — Century Therapeutics, Inc.

Materials · Biological Products, (No Diagnostic Substances) · Nasdaq

CIK 0001850119 · FYE 1231 · All Form 4 filings on EDGAR ↗

3Insiders filing

3Transactions

+$0Reported buys

−$3kReported sells

0Cluster events

Window in data: 2026-09-04 → 2026-09-08 · Data as of 2026-09-10

Insiders

Insider	Role	Txns	Reported value
Russotti Gregory	See Remarks	1	$1k
Pfeiffenberger Brent	President and CEO	1	$977
Carr Douglas	SVP Finance & Operations	1	$521

Transaction history

Filing date	Trade date	Ticker	Insider	Type	Shares	Price	Value	Cluster
2026-09-09	2026-09-08	IPSC	Russotti Gregory See Remarks	S	534	$2.05	−$1k	—
2026-09-09	2026-09-08	IPSC	Carr Douglas SVP Finance & Operations	S	254	$2.05	−$521	—
2026-09-09	2026-09-04	IPSC	Pfeiffenberger Brent President and CEO	F routine	463	$2.11	−$977	—

Known data limitations

Form 4 lag: insiders have 2 business days to file after a trade (weekends and holidays extend this), and this site re-ingests once daily — a transaction can appear here roughly three business days after it happened.
13F lag: quarterly 13F-HR holdings cover the prior quarter-end and are due 45 days after it — every institutional position shown here is at least 45 days old by construction, often more.
CUSIP→ticker gaps: 13F positions are reported by CUSIP; some holdings cannot be matched to a current ticker (delistings, corporate actions, thin metadata) and appear without one or are omitted from ticker-level views.
EDGAR timing variability: institutions file at different hours and days within their windows; amended filings (4/A, 13F-HR/A) can restate earlier periods, so historical aggregates may change between batches.

Insider Atlas is a descriptive research site, not investment advice — see the methodology for the full provenance chain.